Reporting Manager
RA Capital Management, L.P.
Symbol
VOR
Shares outstanding
64,806,628 shares
Disclosed Ownership
12,896,519 shares
Ownership
20%
Form type
SCHEDULE 13D/A
Filing time
21 Apr 2026, 19:05:40 UTC
Date of event
20 Apr 2026
Previous filing
15 Apr 2026

Quoteable Key Fact

"RA CAPITAL MANAGEMENT, L.P. disclosed 20% ownership in VOR BIOPHARMA INC. Common Stock, par value $0.0001 per share (VOR) on 20 Apr 2026."

Quick Takeaways

  • RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13D/A for VOR BIOPHARMA INC. Common Stock, par value $0.0001 per share (VOR).
  • Disclosed ownership: 20%.
  • Date of event: 20 Apr 2026.

What Changed

  • Previous schedule filing date: 15 Apr 2026.
  • Current filing was accepted on 21 Apr 2026, 19:05.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
RA Capital Management, L.P. 20% 12,896,519 0 12,896,519 /s/ Peter Kolchinsky By Peter Kolchinsky, Manager 0001346824
Peter Kolchinsky 20% 12,896,519 0 12,896,519 /s/ Peter Kolchinsky Peter Kolchinsky 0001384859
Rajeev Shah 20% 12,896,519 0 12,896,519 /s/ Rajeev Shah Rajeev Shah 0001619841
RA Capital Healthcare Fund, L.P. 20% 12,889,830 0 12,889,830 /s/ Peter Kolchinsky By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager 0001315082
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .